Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S England

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Acidic triazoles as soluble guanylate cyclase stimulatorsLee R Roberts, Paul A Bradley, Mark E Bunnage, et al.
Journal of Medicinal Chemistry|December 17, 2016
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and SkinPeter Jones, R Ian Storer, Yogesh A Sabnis, et al.
Cell Chemical Biology|March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma CellsAnthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.
European Journal of Medicinal Chemistry|June 4, 2019
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assaysYann-Vaï Le Bihan, Rachel M Lanigan, Butrus Atrash, et al.
Journal of Medicinal Chemistry|January 8, 2016
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase InhibitorsVassilios Bavetsias, Rachel M Lanigan, Gian Filippo Ruda, et al.
Space Science Reviews|February 23, 2022
The Emirates Mars MissionH E S Amiri, D Brain, O Sharaf, et al.
Science (New York, N.Y.)|November 7, 2015
Early MAVEN Deep Dip campaign reveals thermosphere and ionosphere variabilityS Bougher, B Jakosky, J Halekas, et al.
Science (New York, N.Y.)|November 7, 2015
MAVEN observations of the response of Mars to an interplanetary coronal mass ejectionB M Jakosky, J M Grebowsky, J G Luhmann, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Acidic triazoles as soluble guanylate cyclase stimulatorsLee R Roberts, Paul A Bradley, Mark E Bunnage, et al.
Journal of Medicinal Chemistry|December 17, 2016
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and SkinPeter Jones, R Ian Storer, Yogesh A Sabnis, et al.
Cell Chemical Biology|March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma CellsAnthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.
European Journal of Medicinal Chemistry|June 4, 2019
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assaysYann-Vaï Le Bihan, Rachel M Lanigan, Butrus Atrash, et al.
Journal of Medicinal Chemistry|January 8, 2016
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase InhibitorsVassilios Bavetsias, Rachel M Lanigan, Gian Filippo Ruda, et al.
Space Science Reviews|February 23, 2022
The Emirates Mars MissionH E S Amiri, D Brain, O Sharaf, et al.
Science (New York, N.Y.)|November 7, 2015
Early MAVEN Deep Dip campaign reveals thermosphere and ionosphere variabilityS Bougher, B Jakosky, J Halekas, et al.
Science (New York, N.Y.)|November 7, 2015
MAVEN observations of the response of Mars to an interplanetary coronal mass ejectionB M Jakosky, J M Grebowsky, J G Luhmann, et al.
Pageof 7